INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning ...
Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback